In conclusion, we found that downregulation of DNM1 is linked with the onset of CRCI and is consistent in both cancer patients and tumor-bearing mice receiving chemotherapy, strengthening our speculation on DNM1 role as a mediator for CRCI. Here, DNM1 is linked to neoplasm.